1. Home
  2. LFVN vs CING Comparison

LFVN vs CING Comparison

Compare LFVN & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$6.18

Market Cap

78.0M

Sector

Health Care

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.09

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFVN
CING
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
64.5M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
LFVN
CING
Price
$6.18
$5.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$11.00
$34.50
AVG Volume (30 Days)
48.4K
138.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
3.56%
N/A
EPS Growth
N/A
56.47
EPS
0.40
N/A
Revenue
$203,204,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.50
N/A
Revenue Growth
1.86
N/A
52 Week Low
$3.90
$3.16
52 Week High
$12.10
$11.89

Technical Indicators

Market Signals
Indicator
LFVN
CING
Relative Strength Index (RSI) 40.47 48.88
Support Level $6.17 $5.08
Resistance Level $6.97 $5.20
Average True Range (ATR) 0.32 0.30
MACD -0.06 -0.05
Stochastic Oscillator 32.70 22.28

Price Performance

Historical Comparison
LFVN
CING

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: